Highly selective and potent agonists of sphingosine-1-phosphate 1 (S1P1) receptor
作者:Petr Vachal、Leslie M. Toth、Jeffrey J. Hale、Lin Yan、Sander G. Mills、Gary L. Chrebet、Carol A. Koehane、Richard Hajdu、James A. Milligan、Mark J. Rosenbach、Suzanne Mandala
DOI:10.1016/j.bmcl.2006.04.064
日期:2006.7
Novel series of sphingosine-1-phosphate (S1P) receptoragonists were developed through a systematic SAR aimed to achieve high selectivity for a single member of the S1P family of receptors, S1P1. The optimized structure represents a highly S1P1-selective and efficacious agonist: S1P1/S1P2, S1P1/S1P3, S1P1/S1P4>10,000-fold, S1P1/S1P5>600-fold, while EC50 (S1P1) <0.2 nM. In vivo experiments are consistent
Compounds that selectively modulate the sphingosine 1 phosphate receptor are provided including compounds which modulate subtype 1 of the S1P receptor. Methods of chiral synthesis of such compounds is provided. Uses, methods of treatment or prevention and methods of preparing inventive compositions including inventive compounds are provided in connection with the treatment or prevention of diseases, malconditions, and disorders for which modulation of the sphingosine 1 phosphate receptor is medically indicated.
[EN] SELECTIVE HETEROCYCLIC SPHINGOSINE 1 PHOSPHATE RECEPTOR MODULATORS<br/>[FR] MODULATEURS DE RÉCEPTEUR DE SPHINGOSINE-1-PHOSPHATE HÉTÉROCYCLIQUES SÉLECTIFS
申请人:RECEPTOS INC
公开号:WO2011060391A1
公开(公告)日:2011-05-19
Compounds that selectively modulate the sphingosine 1 phosphate receptor are provided including compounds which modulate subtype 1 of the SlP receptor. Methods of chiral synthesis of such compounds is provided. Uses, methods of treatment or prevention and methods of preparing inventive compositions including inventive compounds are provided in connection with the treatment or prevention of diseases, malconditions, and disorders for which modulation of the sphingosine 1 phosphate receptor is medically indicated.